Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - March 2013

5th Ocular Diseases Drug Discovery

21 Mar 2013 - 22 Mar 2013 - San Francisco, USA

Bookmark and Share

The Ocular Diseases & Drug Development Conference taking place on March 21-22, 2013 in San Francisco, CA is now in its fifth year. As chairperson and moderator, I look forward to attending this conference. It continues to offer presentations on novel and innovative therapeutics in ocular drug development and discovery. This year we are fortunate to have Dr. Samir Patel, CEO and President of Ophthotech, as our keynote speaker. A leader in the field, Dr. Patel, a trained retina specialist, will present data from his recent clinical studies on a new and adjunct treatment for wet AMD, Fovista. We have two panels at this year's conference: 1) a safety regulatory panel with experts in the field being moderated by Dr. Ken Mandell and 2) a VC/ BD panel being moderated by Dr. Emmett Cunningham. This forum allows for excellent networking, the exchange of ideas, and sharing of challenges; all with a united common goal of bringing new and innovative treatments to patients in the area of ophthalmology.

The conference features the following topics:

Session: Novel Targets, Developments and Technologies

Session: Novel Drug Delivery Methods to the Anterior and Posterior Segments

Session: Clinical Development Advances & Updates 

Session: Safety Assessment and Regulatory Landscape in Ocular Drug Development

Session: Short Presentations

Panel Discussion: BD, Investments and Potential for Collaborations

Panel Discussion: Safety and Regulatory in Ocular Development

Further information
Scientific News
Inroads Against Leukemia
Potential for halting disease in molecule isolated from sea sponges.
Researchers Disguise Drugs As Platelets to Target Cancer
Researchers have for the first time developed a technique that coats anticancer drugs in membranes made from a patient’s own platelets.
HIV Patients Should Be Included in Early Clinical Trials of Anti-TB Drugs
Tuberculosis is the number one cause of death in HIV-infected patients in Africa and a leading cause of death in this population worldwide.
Combination Drug Therapy Shrinks Pancreatic Tumors In Mice
Two drugs that affect the structure and function of DNA have been found to block the growth of pancreatic tumor cells in mice, researchers hope the drugs can soon be tested in humans with the disease.
Seeking A Better Way To Design Drugs
NIH funds research at Worcester Polytechnic Institute to advance a new chemical process for more effective drug development and manufacturing.
Old Drug Performs New Tricks
Cambridge-led research reveals the powers of a "wonder drug" that has lain under the noses of doctors for 50 years.
Diabetes Drugs May Actually Release Sugar Into the Blood
A family of drugs used to treat Type 2 diabetes could promote the release of sugars into the blood - something the drugs are supposed to prevent, Cambridge scientists have claimed.
Nanoparticles Can Make Medicines More Effective
Nanoparticles wrapped inside human platelet membranes serve as new vehicles for targeted drug delivery.
A Better Class of Cancer Drugs
An SDSU chemist has developed a technique to identify potential cancer drugs that are less likely to produce side effects.
Preventing Crystallization to Improve Drug Efficiency
Esther Amstad and an international team of researchers have developed a method to increase the solubility of poorly soluble substances, such as many of the newly developed drugs.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos